STOCK TITAN

GE HealthCare (NASDAQ: GEHC) director Culp receives restricted and deferred stock units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CULP H LAWRENCE JR reported acquisition or exercise transactions in this Form 4 filing.

GE HealthCare Technologies Inc. director H. Lawrence Culp Jr. reported equity-based compensation awards rather than open-market trades. He received 4,157 restricted stock units and 3,586 fully vested deferred stock units of common stock, both at no cash cost, as part of director compensation. Following these awards, he holds additional common stock directly and also indirectly through family trusts and a holding company.

Positive

  • None.

Negative

  • None.
Insider CULP H LAWRENCE JR
Role null
Type Security Shares Price Value
Grant/Award Common Stock, par value $0.01 per share 3,586 $0.00 --
Grant/Award Common Stock, par value $0.01 per share 4,157 $0.00 --
holding Common Stock, par value $0.01 per share -- -- --
holding Common Stock, par value $0.01 per share -- -- --
Holdings After Transaction: Common Stock, par value $0.01 per share — 16,285 shares (Direct, null); Common Stock, par value $0.01 per share — 151,207 shares (Indirect, By holding company)
Footnotes (1)
  1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan"). Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.
Restricted stock units granted 4,157 units Award of RSUs that vest by May 7, 2027 or next annual meeting
Deferred stock units granted 3,586 units Fully vested deferred stock units in lieu of cash retainer
Direct holdings after RSU award 20,442 shares Total direct common shares following RSU-related entry
Direct holdings after deferred unit entry 16,285 shares Total direct common shares following deferred unit-related entry
Indirect family trust holdings 328,268 shares Common stock held indirectly through family trusts
Indirect holding company shares 151,207 shares Common stock held indirectly through a holding company
restricted stock units financial
"Award of restricted stock units with respect to GE HealthCare Technologies Inc. common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred stock units financial
"Award of fully vested deferred stock units with respect to GE HealthCare common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Non-Employee Director Compensation and Benefits Plan financial
"in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan"
cash retainer financial
"to receive fully vested deferred stock units in lieu of 100% of the cash retainer"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CULP H LAWRENCE JR

(Last)(First)(Middle)
500 WEST MONROE STREET

(Street)
CHICAGO ILLINOIS 60661

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share05/07/2026A3,586(1)(2)A$016,285D
Common Stock, par value $0.01 per share05/07/2026A4,157(2)(3)A$020,442D
Common Stock, par value $0.01 per share151,207IBy holding company
Common Stock, par value $0.01 per share328,268IBy family trusts
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) May 7, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the "Plan").
2. Each restricted stock unit and deferred stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
3. Award of fully vested deferred stock units with respect to GE HealthCare common stock. The reporting person elected, in accordance with the Plan, to receive fully vested deferred stock units in lieu of 100% of the cash retainer awarded to the reporting person. Settlement will occur pursuant to the reporting person's applicable deferral election.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did GEHC director H. Lawrence Culp Jr. acquire in this Form 4?

H. Lawrence Culp Jr. received equity awards, not open-market purchases. He was granted 4,157 restricted stock units and 3,586 fully vested deferred stock units of GE HealthCare common stock as part of his director compensation program.

How and when do the GEHC restricted stock units for H. Lawrence Culp Jr. vest?

The 4,157 restricted stock units will vest 100% on the earlier of GE HealthCare’s next annual stockholders’ meeting or May 7, 2027. After vesting, settlement timing follows the director’s deferral election under the company’s Non-Employee Director Compensation and Benefits Plan.

What are the fully vested deferred stock units reported by GEHC for H. Lawrence Culp Jr.?

The 3,586 deferred stock units are fully vested awards of GE HealthCare common stock units. Culp elected to receive these units instead of 100% of his cash retainer, with settlement timing governed by his deferral election under the company’s director compensation plan.

How many GE HealthCare shares does H. Lawrence Culp Jr. hold indirectly?

The filing shows indirect holdings of 328,268 shares of GE HealthCare common stock through family trusts and 151,207 shares through a holding company. These positions are reported as indirect ownership associated with the director.

What does each GE HealthCare restricted or deferred stock unit represent for H. Lawrence Culp Jr.?

Each restricted stock unit and each deferred stock unit reported represents the right to receive one share of GE HealthCare common stock at settlement. Settlement occurs according to the director’s applicable deferral election under the company’s Non-Employee Director Compensation and Benefits Plan.